Binh Thanh Vu - Concepedia

Author

Binh Thanh Vu

La Roche College ORCID

Also Known As

B. T. VU, B. VU, Binh Thanh Vu, Binh T Vu, Binh T. VU, Binh T. Vu, Binh Thanh Vu, Binh Vu, Binh Thanh Vu, Bình Vũ

Publications

7.4K

Citations

H-Index

Concepts

All Affiliations

La Roche College Vietnam National University Ho Chi Minh City University of California, Los Angeles Ho Chi Minh City International University Roche (Switzerland)

About

Binh Thanh Vu is an author at La Roche College specializing in medicine, pharmacology, and small molecules.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	6K
2	Natural Sciences	6	6	331
3	Biochemistry	4	4	282
4	Engineering	2	2	46
5	Biomolecular Engineering	2	2	63

Binh Thanh Vu

Publications

7.2K

Citations

H-Index

Page 1

	Year	Citations
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 Lyubomir T. Vassilev, Binh Thanh Vu, Bradford Graves, Science Tumor BiologySmall-molecule AntagonistsMdm2-p53 InteractionP53 FunctionChemoprevention Strategy	2004	4.6K
Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: Implications for therapy Christian Tovar, James Rosinski, Zoran Filipovic, Proceedings of the National Academy of Sciences Chemoprevention StrategyApoptosisCell DeathCancer BiologyTumor Biology	2006	699
Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development Binh Thanh Vu, Peter M. Wovkulich, Giacomo Pizzolato, ACS Medicinal Chemistry Letters Drug TargetCell DeathSmall-molecule Mdm2 InhibitorTumor BiologyP53 Activity	2013	373
MDM2 Small-Molecule Antagonist RG7112 Activates p53 Signaling and Regresses Human Tumors in Preclinical Cancer Models Christian Tovar, Bradford Graves, Kathryn Packman, Cancer Research	2013	280
Phosphorylation of p53 on Key Serines Is Dispensable for Transcriptional Activation and Apoptosis Thelma Thompson, Christian Tovar, Hong Yang, Journal of Biological Chemistry	2004	233
Activation of p53 by MDM2 Antagonists Can Protect Proliferating Cells from Mitotic Inhibitors Daisy Carvajal, Christian Tovar, Hong Yang, Cancer Research	2005	201
Chick chorioallantoic membrane assay as an in vivo model to study the effect of nanoparticle-based anticancer drugs in ovarian cancer Binh Thanh Vu, Sophia Allaf Shahin, Jonas G. Croissant, Scientific Reports	2018	144
Discovery of [4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6- methoxyphenyl)methanone (R547), A Potent and Selective Cyclin-Dependent Kinase Inhibitor with Significant in Vivo Antitumor Activity Xin‐Jie Chu, Wanda DePinto, David Bartkovitz, Journal of Medicinal Chemistry Drug TargetPharmacotherapyCell CycleChemical BiologyPharmaceutical Chemistry	2006	116
Applications of Vinylogous Mannich Reactions. Total Syntheses of the <i>Ergot</i> Alkaloids Rugulovasines A and B and Setoclavine Spiros Liras, Christopher L. Lynch, Andrew M. Fryer, Journal of the American Chemical Society	2001	91
NMR structure of a complex between MDM2 and a small molecule inhibitor David C. Fry, S. Donald Emerson, Stefan Palme, Journal of Biomolecular NMR BiochemistryNmr StructureNatural SciencesMedicineMolecular Biology	2004	74

Page 1